Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

HAE
Haemonetics Corporation
stock NYSE

Market Open
Aug 11, 2026 1:35:02 PM EDT
87.42USD+0.976%(+0.85)232,146
75.83Bid   100.32Ask   24.49Spread
Pre-market
0.00USD-100.000%(-87.84)0
After-hours
Aug 10, 2026 4:10:30 PM EDT
86.61USD+0.046%(+0.04)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022   Benzinga
05:55AM EST  Needham Downgrades Haemonetics to Hold   Benzinga
Jan 7, 2022
01:04PM EST  Morgan Stanley Maintains Equal-Weight on Haemonetics, Lowers Price Target to $60   Benzinga
Jan 5, 2022
08:01AM EST  Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results:   PR Newswire
Dec 15, 2021
10:05AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021   Benzinga
07:05AM EST  Citigroup Downgrades Haemonetics to Neutral   Benzinga
Nov 10, 2021
07:45AM EST  JMP Securities Maintains Market Outperform on Haemonetics, Lowers Price Target to $80   Benzinga
05:06AM EST  Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $70   Benzinga
Nov 9, 2021
12:08PM EST  Looking Into Haemonetics's Return On Capital Employed   Benzinga
11:42AM EST  The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data   Benzinga
11:28AM EST  Haemonetics Cuts FY22 Organic Revenue Growth Guidance From 8-12% To 7-10%   Benzinga
11:27AM EST  Haemonetics Q2 Adj. EPS $0.60 Misses $0.61 Estimate, Sales $239.90M Miss $241.40M Estimate   Benzinga
11:26AM EST  Haemonetics Announced CFO William P. Burke to Retire in June 2022   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
06:54AM EST  Haemonetics Corporation (HAE) on Tuesday said its Executive Vice President, Chief Financial Officer, William Burke would retire in June 2022.   RTTNews
06:44AM EST  Haemonetics Corporation (HAE) on Tuesday reported lower earnings in the second quarter despite rise in revenue. It also narrowed the outlook range for organic revenue growth for the full year.   RTTNews
06:03AM EST  Haemonetics Q2 EPS $0.29; CFO William Burke To Retire   RTTNews
06:01AM EST  Haemonetics Announces CFO William P. Burke's Retirement for June 2022   PR Newswire
06:01AM EST  Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor   PR Newswire
Nov 8, 2021
08:29AM EST  The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More   Benzinga
Oct 6, 2021
04:10PM EDT  Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results:   PR Newswire
Oct 1, 2021
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
06:39AM EDT  Haemonetics' Vascade Vascular Closure Device Includes Same-Day Discharge Label   Benzinga
Sep 30, 2021
04:12PM EDT  Haemonetics Announces VASCADE MVP Venous Vascular Closure System Gains The First And Only FDA Approval For Same-Day Discharge Following Atrial Fibrillation Ablation   Benzinga
04:11PM EDT  First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation   PR Newswire
Aug 25, 2021
08:53AM EDT  Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare   PR Newswire
Aug 11, 2021
11:11AM EDT  Looking into Haemonetics's Return on Capital Employed   Benzinga
09:06AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
07:04AM EDT  Recap: Haemonetics Q1 Earnings   Benzinga
06:36AM EDT  Haemonetics Corp. (HAE), a medical technology company, reported Wednesday that its first-quarter net loss was $4.5 million or $0.09 per share, compared to net income of $10.5 million or $0.21 per share a year ago.   RTTNews
06:11AM EDT  UPDATE: Haemonetics Sees FY22 GAAP Sales Guidance For Co.'s Vascular Closure Unit $75M-$85M   Benzinga
06:10AM EDT  UPDATE: Haemonetics Reaffirms FY22 Adj. EPS $2.60-$3 vs $2.78 Estiamte   Benzinga
06:09AM EDT  Haemonetics Sees FY22 GAAP Sales Growth 13-18% Year Over Year   Benzinga
06:09AM EDT  Haemonetics Q1 Adj. EPS $0.50 Beats $0.46 Estimate, Sales $229.00M Beat $219.35M Estimate; Raises FY22 Guidance For Vascular Closure Sales   Benzinga
06:05AM EDT  Haemonetics Q1 Loss Per Share $0.09; Adj EPS $0.50   RTTNews
06:01AM EDT  Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor   PR Newswire
04:27AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
06:48AM EDT  Haemonetics Announces Election Of Lloyd Johnson To Board Of Directors   RTTNews
06:45AM EDT  Lloyd E. Johnson Joins Haemonetics' Board of Directors; Ellen Zane Announced as   PR Newswire
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Jul 9, 2021
04:52PM EDT  /C O R R E C T I O N -- Haemonetics Corporation/   PR Newswire
04:10PM EDT  Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results:   PR Newswire
Jul 1, 2021
07:28AM EDT  Cramer Gives His Opinion On Virgin Galactic, Zynex And More   Benzinga
Jun 17, 2021
10:58AM EDT  What 8 Analyst Ratings Have To Say About Haemonetics   Benzinga
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2021   Benzinga
09:18AM EDT  Citigroup Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $75   Benzinga
May 14, 2021
11:54AM EDT  CJS Securities Upgrades Haemonetics to Outperform   Benzinga
10:38AM EDT  What Does Haemonetics Debt Look Like?   Benzinga
10:38AM EDT  A Look Into Haemonetics Price Over Earnings   Benzinga
10:34AM EDT  Where Haemonetics Stands With Analysts   Benzinga
09:03AM EDT  JMP Securities Maintains Market Outperform on Haemonetics, Lowers Price Target to $90   Benzinga
08:57AM EDT  Jefferies Maintains Buy on Haemonetics, Lowers Price Target to $85   Benzinga
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
07:38AM EDT  Morgan Stanley Maintains Equal-Weight on Haemonetics, Lowers Price Target to $75   Benzinga
May 13, 2021
10:30AM EDT  Mid-Morning Market Update: Markets Open Higher; US Jobless Claims Decline To 473,000   Benzinga
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
07:11AM EDT  Recap: Haemonetics Q4 Earnings   Benzinga
06:31AM EDT  Haemonetics Corp. (HAE) Thursday reported fourth-quarter net loss of $11.04 million compared to profit of $17.62 million in the prior year. On a per-share basis, loss was $0.22, compared to profit of $0.34 a year ago. On average, 7 analysts polled by Thomson Reuters expected the company to earn $0.67 per shares. Analysts estimates usually exclude special items.   RTTNews
06:21AM EDT  Haemonetics Sees FY22 Adj. EPS $2.60-$3.00 May Not Compare To $3.48 Est.   Benzinga
06:20AM EDT  Haemonetics Q4 Adj. EPS $0.46 Misses $0.67 Estimate, Sales $225.03M Beat $222.98M Estimate   Benzinga
06:05AM EDT  Haemonetics Q4 Loss Per Share $0.22; Adj EPS $0.46   RTTNews
06:01AM EDT  Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor   PR Newswire
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 5, 2021
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
Apr 29, 2021
07:24AM EDT  Peer-Reviewed Results Of Haemonetics' Improving Plasma Collection Trial Published   RTTNews
06:46AM EDT  Peer-Reviewed Results of Haemonetics' Improving Plasma Collection (IMPACT)   PR Newswire
Apr 23, 2021
04:05PM EDT  Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2021   PR Newswire
Apr 22, 2021
08:09AM EDT  The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs   Benzinga
Apr 20, 2021
11:59AM EDT  Morgan Stanley Downgrades Haemonetics to Equal-Weight, Lowers Price Target to $83   Benzinga
10:44AM EDT  Needham Maintains Buy on Haemonetics, Lowers Price Target to $108   Benzinga
10:38AM EDT  Barrington Research Maintains Outperform on Haemonetics, Lowers Price Target to $91   Benzinga
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 19, 2021
02:31PM EDT  Mid-Afternoon Market Update: Nasdaq Tumbles 150 Points; Knoll Shares Spike Higher   Benzinga
12:26PM EDT  Needham Maintains Buy on Haemonetics, Lowers Price Target to $108   Benzinga
12:20PM EDT  Mid-Day Market Update: Marlin Business Services Rises Following Acquisition News; Anixa Biosciences Shares Plummet   Benzinga
10:27AM EDT  Mid-Morning Market Update: Markets Open Lower; Coca-Cola Tops Q1 Views   Benzinga
06:06AM EDT  Haemonetics Announces CSL Pharma Has Informed Co. Of Its Intent Not To Renew Its Supply Agreement With Haemonetics For The Use of PCS2 Plasma Collection System Devices   Benzinga
06:01AM EDT  Haemonetics Provides Update On U.S. Plasma Business   PR Newswire
Mar 2, 2021
08:23PM EST  Haemonetics Prices $435.0 Million Convertible Senior Notes Offering   PR Newswire
08:01AM EST  The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data   Benzinga
Mar 1, 2021
04:06PM EST  Haemonetics Announces Proposed Convertible Senior Notes Offering   PR Newswire
Feb 26, 2021
06:50AM EST  Haemonetics To Present At The Jefferies Plasma Summit   PR Newswire
Feb 12, 2021
07:35AM EST  Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $155   Benzinga
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 3, 2021
10:32AM EST  Barrington Research Upgrades Haemonetics to Outperform, Announces $140 Price Target   Benzinga
09:11AM EST  Morgan Stanley Maintains Overweight on Haemonetics, Raises Price Target to $147   Benzinga
08:13AM EST  Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $145   Benzinga
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
Feb 2, 2021
08:05AM EST  The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment   Benzinga
07:09AM EST  Recap: Haemonetics Q3 Earnings   Benzinga
06:18AM EST  Healthcare company Haemonetics Corp. (HAE) reported Tuesday that net income for the third quarter grew to $31.88 million or $0.62 per share from $29.90 million or $0.58 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.81 per share, compared to last year's $0.94 per share.   RTTNews
06:17AM EST  Haemonetics Q3 Adj. EPS $0.81 Beats $0.65 Estimate, Sales $240.37M Beat $224.29M Estimate   Benzinga
06:04AM EST  Haemonetics Q3 Revenue $240.4 Mln, Down 7.2% From Last Year   RTTNews
06:01AM EST  Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor   PR Newswire
04:00AM EST  Earnings Scheduled For February 2, 2021   Benzinga
Jan 30, 2021
01:19PM EST  The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More   Benzinga
Jan 22, 2021
07:01AM EST  Haemonetics Corp. (HAE) said Friday it supports new guidance issued by the U.S. Food and Drug Administration or FDA related to the use of viscoelastic testing for the duration of the public health emergency related to COVID-19.   RTTNews
06:48AM EST  Haemonetics Says Welcomes FDA Guidance On Viscoelastic Testing During COVID-19 Pandemic   RTTNews
06:46AM EST  Haemonetics Affirms Support Of New Guidance Issued By FDA Related To Use Of Viscoelastic Testing For Duration Of Public Health Emergency Related To COVID-19   Benzinga
06:45AM EST  Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19   PR Newswire
Jan 21, 2021
10:41AM EST  Barrington Research Downgrades Haemonetics to Market Perform   Benzinga
Jan 20, 2021
11:05AM EST  Needham Maintains Buy on Haemonetics, Raises Price Target to $142   Benzinga
06:58AM EST  Haemonetics Corp. (HAE), a medical technology company, said Wednesday it has agreed to acquire privately-held Cardiva Medical, Inc., a Santa Clara, California-based manufacturer of vascular closure systems. The company noted that the acquisition will enable it to expand its hospital portfolio.   RTTNews
06:47AM EST  Haemonetics To Acquire Cardiva Medical For Upfront Cash Payment Of $475M At Closing And Up To Additional $35M In Contingent Considerations   Benzinga
06:46AM EST  Haemonetics To Acquire Privately-held Cardiva Medical   RTTNews
06:45AM EST  Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio   PR Newswire
Jan 8, 2021
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 7, 2021
09:45AM EST  Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $135   Benzinga
Jan 5, 2021
05:04PM EST  Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2021 Results:   PR Newswire
Dec 15, 2020
12:09PM EST  Morgan Stanley Maintains Overweight on Haemonetics, Raises Price Target to $139   Benzinga
Nov 5, 2020
05:47AM EST  Barrington Research Upgrades Haemonetics to Outperform   Benzinga
Nov 4, 2020
08:21AM EST  The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings   Benzinga
07:11AM EST  Haemonetics: Q2 Earnings Insights   Benzinga
06:14AM EST  Healthcare company Haemonetics Corp. (HAE) reported Tuesday that net income for the second quarter grew to $48.10 million or $0.94 per share from $37.49 million or $0.72 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.62 per share, compared to last year's $0.87 per share.   RTTNews
06:10AM EST  Haemonetics Q2 EPS $0.62 Beats $0.51 Estimate, Sales $209.49M Beat $207.65M Estimate   Benzinga
06:03AM EST  Haemonetics Q2 EPS $0.94; Adj EPS $0.62   RTTNews
06:00AM EST  Haemonetics 2nd Quarter Fiscal Year 2021 Earnings Release Available on Investor   PR Newswire
04:41AM EST  Earnings Scheduled For November 4, 2020   Benzinga
Nov 2, 2020
08:22AM EST  Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $130   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 6, 2020
04:15PM EDT  Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2021 Results:   PR Newswire
Oct 5, 2020
06:00AM EDT  Haemonetics Announced Late Friday it Received FDA Clearance For NexSys PCS With Persona Technology   Benzinga
Oct 2, 2020
08:37PM EDT  Haemonetics Receives FDA Clearance For NexSys PCS(r) With Persona(tm) Technology   PR Newswire
Sep 9, 2020
04:54PM EDT  Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare   PR Newswire
Sep 8, 2020
08:37AM EDT  10 Biggest Price Target Changes For Tuesday   Benzinga
07:27AM EDT  Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $100   Benzinga
Aug 7, 2020
06:56AM EDT  Haemonetics To Npresent Results Of IMPACT Study At The 2020 AABB Annual Meeting   RTTNews
06:46AM EDT  Haemonetics Reports Will Present Its IMPACT Study At Annual Meeting in a Plenary Oral Abstract Session on October 4   Benzinga
06:45AM EDT  Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma   PR Newswire
Aug 5, 2020
07:29AM EDT  Raymond James Maintains Outperform on Haemonetics, Lowers Price Target to $93   Benzinga
Aug 4, 2020
11:03AM EDT  Shares of healthcare company, providing hematology products and solutions, Haemonetics Corporation (HAE) are down more than 8% Tuesday morning at $80.01. It has traded in the range of $63.41- $140.36 in the past one year.   RTTNews
07:28AM EDT  Haemonetics: Q1 Earnings Insights   Benzinga
07:03AM EDT  Healthcare company Haemonetics Corp. (HAE) reported Tuesday a net income for the first quarter of $10.53 million or $0.21 per share, compared to a net loss of $8.48 million or $0.17 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.46 per share, compared to last year's $0.81 per share.   RTTNews
06:14AM EDT  Haemonetics Q1 Adj. EPS $0.46 Beats $0.41 Estimate, Sales $196.00M Miss $198.27M Estimate   Benzinga
06:11AM EDT  Haemonetics Q1 EPS $0.21; Adj EPS $0.46   RTTNews
06:01AM EDT  Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor   PR Newswire
05:19AM EDT  Earnings Scheduled For August 4, 2020   Benzinga
Jul 24, 2020
06:47AM EDT  Haemonetics Enters Definitive Agreement To Sell Its Wholly-owned Subsidiary Inlog Holdings France SAS To Abne   RTTNews
06:47AM EDT  Haemonetics Reports Sale Of Wholly-Owned Subsidiary, Inlog Holdings France To Abenex, No Terms Disclosed   Benzinga
06:45AM EDT  Haemonetics Announces Sale Of Inlog Holdings France SAS To Abnex Capital   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC